How much funding does Oligonucleotide Therapeutic Society: Travel Grants provide?

Oligonucleotide Therapeutic Society: Travel Grants provides US $1,000 - US $1,500 in funding.

When is the deadline for Oligonucleotide Therapeutic Society: Travel Grants?

The funder has not published a deadline for this grant.

Oligonucleotide Therapeutic Society: Travel Grants

Oligonucleotide Therapeutics Society

Foundation Grants for Science Research

Funding Amount

US $1,000 - US $1,500

Deadline

Deadline not published

Grant Type

Foundation

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

Be a current member of OTS Be a current graduate student or post-doc

Other requirements

Be the first author of an abstract to be presented as a poster or short talk at the annual meeting
Submit an abstract of high scientific merit
You must be a member of this organization to apply for this award - become a member.

Not eligible / not funded

Not eligible: Prior award winners are not eligible

Overview

The Oligonucleotide Therapeutics Society provides Travel Grants aimed at exceptional doctorate graduate students and post-doctoral researchers. This grant offers financial support to cover travel expenses for attending the OTS Annual Meeting. Eligible candidates must be current members of OTS, be graduate students or post-docs, and present high-quality scientific abstracts. The grants include stipends of $1,000 for intra-continental travel and $1,500 for intercontinental travel, promoting collaboration and innovation in oligonucleotide research.

The Oligonucleotide Therapeutics Society offers Travel Grants for outstanding doctorate graduate students and post-docs. The grant includes a stipend to offset travel expenses for the OTS Annual Meeting.
Incorporated in 2004 as a 501(c)6 nonprofit and registered with the U.S. government, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics.
The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities,very much like the impact that antibodies had on human therapeutics over the last decade.
Recipients receive:

For travel within the same continent = $1,000 USDFor travel from outside the continent = $1,500 USD

Eligibility

Be a current member of OTS Be a current graduate student or post-doc
Be the first author of an abstract to be presented as a poster or short talk at the annual meeting
Submit an abstract of high scientific merit
You must be a member of this organization to apply for this award - become a member.